Literature DB >> 11575384

Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection.

R J Kavanagh1, P C Kam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11575384     DOI： 10.1093/bja/86.1.110

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  12 in total

Review 1.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

Review 2.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.

Authors:  Erica K M Reeves; Eric P Hoffman; Kanneboyina Nagaraju; Jesse M Damsker; John M McCall
Journal:  Bioorg Med Chem       Date:  2013-02-18       Impact factor: 3.641

4.  Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effects.

Authors:  Andreas R Baudy; Erica K M Reeves; Jesse M Damsker; Christopher Heier; Lindsay M Garvin; Blythe C Dillingham; John McCall; Sree Rayavarapu; Zuyi Wang; Jack H Vandermeulen; Arpana Sali; Vanessa Jahnke; Stephanie Duguez; Debra DuBois; Mary C Rose; Kanneboyina Nagaraju; Eric P Hoffman
Journal:  J Pharmacol Exp Ther       Date:  2012-06-28       Impact factor: 4.030

Review 5.  Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review.

Authors:  Peter Gál; Petra Kravcuková; Michal Mokrý; Darina Kluchová
Journal:  Cell Mol Neurobiol       Date:  2009-04-11       Impact factor: 5.046

6.  Pharmacological inhibition of lipid peroxidative damage by the 21-aminosteroid U-74389G improves cortical mitochondrial function following traumatic brain injury in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Jennifer Brelsfoard; Edward D Hall
Journal:  Neuropharmacology       Date:  2020-03-03       Impact factor: 5.250

Review 7.  Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy.

Authors:  Eric P Hoffman; Erica Reeves; Jesse Damsker; Kanneboyina Nagaraju; John M McCall; Edward M Connor; Kate Bushby
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-11       Impact factor: 1.784

8.  Effects of hypoxia exposure on hepatic cytochrome P450 1A (CYP1A) expression in Atlantic croaker: molecular mechanisms of CYP1A down-regulation.

Authors:  Md Saydur Rahman; Peter Thomas
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

9.  VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.

Authors:  Christopher R Heier; Jesse M Damsker; Qing Yu; Blythe C Dillingham; Tony Huynh; Jack H Van der Meulen; Arpana Sali; Brittany K Miller; Aditi Phadke; Luana Scheffer; James Quinn; Kathleen Tatem; Sarah Jordan; Sherry Dadgar; Olga C Rodriguez; Chris Albanese; Michael Calhoun; Heather Gordish-Dressman; Jyoti K Jaiswal; Edward M Connor; John M McCall; Eric P Hoffman; Erica K M Reeves; Kanneboyina Nagaraju
Journal:  EMBO Mol Med       Date:  2013-09-09       Impact factor: 12.137

Review 10.  Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury.

Authors:  André Mendes Arent; Luiz Felipe de Souza; Roger Walz; Alcir Luiz Dafre
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.